Andrea B. Smith - 24 Apr 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Director
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
24 Apr 2023
Net transactions value
$0
Form type
4
Filing time
26 Apr 2023, 17:11:04 UTC
Previous filing
02 May 2022
Next filing
01 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +663 +30% $0.000000 2,902 24 Apr 2023 Direct F1
holding HCA Common Stock 82 24 Apr 2023 By managed accounts F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock underlying 663 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2024 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.
F2 The shares reported herein are held in fully managed accounts over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein.